Neurotech, a developer of active implantable devices, has received CE mark approval for its ADNS-300 to treat refractory epilepsy. The surgically implanted ADNS-300 system operates as a pacemaker to produce stimulation towards the brain ...
Tags: active implantable devices, Neurotech, refractory epilepsy